CAS 19178-19-9
:4(1H)-Quinazolinone, 5,6,7,8-tetrahydro- (9CI)
Description:
4(1H)-Quinazolinone, 5,6,7,8-tetrahydro- (CAS 19178-19-9) is a bicyclic organic compound characterized by its quinazolinone structure, which consists of a fused benzene and pyrimidine ring system. This compound features a tetrahydro configuration, indicating the presence of four hydrogen atoms that saturate the ring, resulting in a more stable, saturated form compared to its unsaturated counterparts. It is typically a white to off-white solid, and its solubility can vary depending on the solvent used, often being more soluble in polar organic solvents. The compound is of interest in medicinal chemistry due to its potential biological activities, including antimicrobial and anticancer properties. Its structural features allow for various chemical modifications, which can enhance its pharmacological profile. Additionally, it may serve as a building block in the synthesis of more complex molecules in drug development. As with many quinazolinone derivatives, it may exhibit a range of biological activities, making it a subject of research in various fields, including pharmaceuticals and agrochemicals.
Formula:C8H10N2O
InChI:InChI=1/C8H10N2O/c11-8-6-3-1-2-4-7(6)9-5-10-8/h5H,1-4H2,(H,9,10,11)
SMILES:C1CCc2c(C1)c(ncn2)O
Synonyms:- 4(3H)-Quinazolinone, 5,6,7,8-tetrahydro-
- 5,6,7,8-Tetrahydro-4(3H)-quinazolinone
- Tetrahydro-5,6,7,8 (3H) quinazolinone-4
- Tetrahydro-5,6,7,8 (3H) quinazolinone-4 [French]
- 5,6,7,8-tetrahydroquinazolin-4(1H)-one
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
4(1H)-Quinazolinone, 5,6,7,8-tetrahydro- (9CI)
CAS:Formula:C8H10N2OPurity:98%Color and Shape:SolidMolecular weight:150.17785,6,7,8-Tetrahydro-3H-quinazolin-4-one
CAS:<p>5,6,7,8-Tetrahydro-3H-quinazolin-4-one</p>Purity:95%Molecular weight:150.18g/mol5,6,7,8-Tetrahydro-3H-quinazolin-4-one
CAS:<p>5,6,7,8-Tetrahydro-3H-quinazolin-4-one is a pharmacological agent that is structurally related to the benzyl and piperidino groups. It has a low toxicity and can be used in peptic ulcer disease, as well as other conditions where this type of drug is indicated. 5,6,7,8-Tetrahydro-3H-quinazolin-4-one has shown some efficacy in treating duodenal ulcers. The drug binds to the H+/K+ ATPase enzyme in the stomach and inhibits gastric acid secretion by binding to the proton pump at the cellular level. This prevents it from functioning normally.</p>Formula:C8H10N2OPurity:Min. 95%Molecular weight:150.18 g/mol



